Sleep disruption in breast cancer patients and survivors

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 11, Issue 12, 2013, Pages 1523-5930

  Palesh, Oxana ^a   Aldridge Gerry, Arianna ^a   Ulusakarya, Ayhan ^b   Ortiz Tudela, Elisabet ^c,d   Capuron, Lucile ^e,f   Innominato, Pasquale F ^b,d  

^a STANFORD UNIVERSITY   (United States)

^b HÔPITAL PAUL BROUSSE   (France)

^c UNIVERSITY OF MURCIA   (Spain)

^d INSERM   (France)

^e NutriNeuro Bordeaux University   (France)

^f UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC AGENT;

AGE; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVOR; CANCER THERAPY; CIRCADIAN RHYTHM; CLINICAL PRACTICE; COGNITIVE THERAPY; DEPRESSION; EXERCISE; FATIGUE; HUMAN; IMMUNITY; METABOLIC REGULATION; PHARMACEUTICAL CARE; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; SLEEP; SLEEP DISORDER; SLEEP WAKING CYCLE; STRESS;

BREAST NEOPLASMS; CIRCADIAN CLOCKS; FEMALE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SLEEP DISORDERS; SURVIVORS;

EID: 84891936146     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2013.0179     Document Type: Article

References (79)

1. Palesh OG, Roscoe JA, Mustian KM, et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol 2010;28:292-298.
2. Savard J, Ivers H, Villa J, et al. Natural course of insomnia comorbid with cancer: an 18-month longitudinal study. J Clin Oncol 2011;29:3580-3586.
3. Palesh OG, Collie K, Batiuchok D, et al. A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol 2007;75:37-44.
4. Koopman C, Nouriani B, Erickson V, et al. Sleep disturbances in women with metastatic breast cancer. Breast J 2002;8:362-370.
5. Berger AM, Wielgus K, Hertzog M, et al. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/ depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer 2010;18:105-114.
6. Savard J, Liu L, Natarajan L, et al. Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep 2009;32:1155-1160.
7. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000;92:994-1000.
8. Kondratova AA, Kondratov RV. The circadian clock and pathology of the ageing brain. Nat Rev Neurosci 2012;13:325-335.
9. Garaulet M, Madrid JA. Chronobiological aspects of nutrition, metabolic syndrome and obesity. Adv Drug Deliv Rev 2010;62:967-978.
10. Cochrane A, Robertson IH, Coogan AN. Association between circadian rhythms, sleep and cognitive impairment in healthy older adults: an actigraphic study. J Neural Transm 2012;119:1233-1239.
11. Innominato PF, Levi FA, Bjarnason GA. Chronotherapy and the molecular clock: clinical implications in oncology. Adv Drug Deliv Rev 2010;62:979-1001.
12. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001;933:222-234.
13. Krueger JM, Takahashi S, Kapas L, et al. Cytokines in sleep regulation. Adv Neuroimmunol 1995;5:171-188.
14. Opp MR, Born J, Irwin MR. Sleep and the immune system. In: Ader R, ed. Psychoneuroimmunology. Vol. 4. New York, NY: Academic Press; 2007:579-618.
15. Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011;130:226-238.
16. Rich T, Innominato PF, Boerner J, et al. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 2005;11:1757-1764.
17. Mills PJ, Parker B, Dimsdale JE, et al. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biol Psychol 2005;69:85-96.
18. Schubert C, Hong S, Natarajan L, et al. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun 2007;21:413-427.
19. Opp MR. Cytokines and sleep. Sleep Med Rev 2005;9:355-364.
20. Liu L, Mills PJ, Rissling M, et al. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun 2012;26:706-713.
21. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003;112:1785-1788.
22. Panossian LA, Veasey SC. Daytime sleepiness in obesity: mechanisms beyond obstructive sleep apnea-a review. Sleep 2012;35:605-615.
23. Lucassen EA, Rother KI, Cizza G. Interacting epidemics? Sleep curtailment, insulin resistance, and obesity. Ann N Y Acad Sci 2012;1264:110-134.
24. Berger AM, Gerber LH, Mayer DK. Cancer-related fatigue: implications for breast cancer survivors. Cancer 2012;118(8 Suppl):2261-2269.
25. Gerber LH, Stout N, McGarvey C, et al. Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer 2011;19:1581-1591.
26. Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 1987;10:541-553.
27. Morin C. Insomnia: Psychological Assessment and Management. New York: Guilford Press; 1993.
28. Hunter MS, Grunfeld EA, Mittal S, et al. Menopausal symptoms in women with breast cancer: prevalence and treatment preferences. Psychooncology 2004;13:769-778.
29. Carpenter JS, Johnson D, Wagner L, Andrykowski M. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 2002;29:E16-25.
30. Kravitz HM, Ganz PA, Bromberger J, et al. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10:19-28.
31. Colagiuri B, Christensen S, Jensen AB, et al. Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery. J Pain Symptom Manage 2011;42:710-720.
32. Akechi T, Okuyama T, Akizuki N, et al. Associated and predictive factors of sleep disturbance in advanced cancer patients. Psychooncology 2007;16:888-894.
33. Lorizio W, Wu AH, Beattie MS, et al. Clinical and biomarker predictors of side effects from tamoxifen. Breast Cancer Res Treat 2012;132:1107-1118.
34. Savard J, Ivers H. The initiation of chemotherapy, but not radiation therapy, coincides with increased insomnia. Psychooncology 2012;21:37-38.
35. Palesh O, Peppone L, Innominato PF, et al. Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer. Nat Sci Sleep 2012;4:151-162.
36. Palesh O, Koopman C. Breast cancer: post-traumatic stress disorder-prevalent and persistent. Nat Rev Clin Oncol 2013;10:252-254.
37. Vin-Raviv N, Hillyer GC, Hershman DL, et al. Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. J Natl Cancer Inst 2013;105:563-572.
38. Grandner MA, Hale L, Jackson N, et al. Perceived racial discrimination as an independent predictor of sleep disturbance and daytime fatigue. Behav Sleep Med 2012;10:235-249.
39. Thomas KS, Bardwell WA, Ancoli-Israel S, Dimsdale JE. The toll of ethnic discrimination on sleep architecture and fatigue. Health Psychol 2006;25:635-642.
40. Tomfohr L, Pung MA, Edwards KM, Dimsdale JE. Racial differences in sleep architecture: the role of ethnic discrimination. Biol Psychol 2012;89:34-38.
41. Otte JL, Carpenter JS, Russell KM, et al. Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J Pain Symptom Manage 2010;39:535-547.
42. Beatty DL, Hall MH, Kamarck TA, et al. Unfair treatment is associated with poor sleep in African American and Caucasian adults: Pittsburgh SleepSCORE project. Health Psychol 2011;30:351-359.
43. Palesh OG, Mustian KM, Peppone LJ, et al. Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Sleep Med 2012;13:1184-1190.
44. Bower JE. Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 2008;26:768-777.
45. Reich M, Lesur A, Perdrizet-Chevallier C. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 2008;110:9-17.
46. Vargas S, Wohlgemuth WK, Antoni MH, et al. Sleep dysfunction and psychosocial adaptation among women undergoing treatment for non-metastatic breast cancer. Psychooncology 2010;19:669-673.
47. Ancoli-Israel S, Liu L, Marler MR, et al. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 2006;14:201-209.
48. Berger AM, Farr LA, Kuhn BR, et al. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage 2007;33:398-409.
49. Phillips KM, Jim HS, Donovan KA, et al. Characteristics and correlates of sleep disturbances in cancer patients. Support Care Cancer 2012;20:357-365.
50. Berger AM, Kuhn BR, Farr LA, et al. One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue. J Clin Oncol 2009;27:6033-6040.
51. Fiorentino L, Ancoli-Israel S. Sleep dysfunction in patients with cancer. Curr Treat Options Neurol 2007;9:337-346.
52. Parker KP, Bliwise DL, Ribeiro M, et al. Sleep/wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J Clin Oncol 2008;26:2464-2472.
53. Silberfarb PM, Hauri PJ, Oxman TE, Schnurr P. Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol 1993;11:997-1004.
54. Roscoe JA, Perlis ML, Pigeon WR, et al. Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapy. J Psychosom Res 2011;71:423-428.
55. Palesh O, Aldridge-Gerry A, Zeitzer J, et al. Actigraphy measured sleep disruption as a predictor of survival among women with advanced breast cancer [abstract]. J Clin Oncol 2013;31(Suppl):Abstract 9532.
56. Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep 2006;29:1415-1419.
57. Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol 2005;23:6083-6096.
58. Espie CA, Fleming L, Cassidy J, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 2008;26:4651-4658.
59. Berger AM, Kuhn BR, Farr LA, et al. Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue. Psychooncology 2009;18:634-646.
60. Barsevick A, Beck SL, Dudley WN, et al. Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy. J Pain Symptom Manage 2010;40:200-216.
61. Costantini C, Ale-Ali A, Helsten T. Sleep aid prescribing practices during neoadjuvant or adjuvant chemotherapy for breast cancer. J Palliat Med 2011;14:563-566.
62. Casault L, Savard J, Ivers H, et al. Utilization of hypnotic medication in the context of cancer: predictors and frequency of use. Support Care Cancer 2012;20:1203-1210.
63. Riechelmann RP, Tannock IF, Wang L, et al. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst 2007;99:592-600.
64. Jacobsen PB, Massie MJ, Kinne DW, Holland JC. Hypnotic efficacy and safety of triazolam administered during the postoperative period. Gen Hosp Psychiatry 1994;16:419-425.
65. Hansen MV, Madsen MT, Hageman I, et al. The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial. BMJ Open 2012;2:e000647.
66. Mock V, Dow KH, Meares CJ, et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997;24:991-1000.
67. Van Someren EJ, Lijzenga C, Mirmiran M, Swaab DF. Long-term fitness training improves the circadian rest-activity rhythm in healthy elderly males. J Biol Rhythms 1997;12:146-156.
68. Norman JF, Von Essen SG, Fuchs RH, McElligott M. Exercise training effect on obstructive sleep apnea syndrome. Sleep Res Online 2000;3:121-129.
69. Tanaka H, Taira K, Arakawa M, et al. Effects of short nap and exercise on elderly people having difficulty in sleeping. Psychiatry Clin Neurosci 2001;55:173-174.
70. King AC, Oman RF, Brassington GS, et al. Moderate-intensity exercise and self-rated quality of sleep in older adults. A randomized controlled trial. JAMA 1997;277:32-37.
71. Tworoger SS, Yasui Y, Vitiello MV, et al. Effects of a yearlong moderate-intensity exercise and a stretching intervention on sleep quality in postmenopausal women. Sleep 2003;26:830-836.
72. Humpel N, Iverson DC. Sleep quality, fatigue and physical activity following a cancer diagnosis. Eur J Cancer Care (Engl) 2010;19:761-768.
73. Young-McCaughan S, Mays MZ, Arzola SM, et al. Research and commentary: change in exercise tolerance, activity and sleep patterns, and quality of life in patients with cancer participating in a structured exercise program. Oncol Nurs Forum 2003;30:441-454; discussion 441-454.
74. Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care (Engl) 2001;10:245-255.
75. Neikrug AB, Rissling M, Trofimenko V, et al. Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer. Behav Sleep Med 2012;10:202-216.
76. Mustian M, Sprod L, Peppone L, et al. Effect of YOCAS yoga on circadian rhythm, anxiety, and mood: a URCC CCOP randomized, controlled clinical trial among 410 cancer survivors [abstract]. J Clin Oncol 2011;29(Suppl):Abstract 9034.
77. Mustian KM, Sprod LK, Janelsins M, et al. Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol 2013;10;31:3233-3241.
78. Denlinger CS, Carlson RW, Are M, et al. NCCN Clinical Practice Guidelines in Oncology: Survivorship. Version 1, 2013. Available at: NCCN.org. Accessed November 14, 2013.
79. Ortiz-Tudela E, Martinez-Nicolas A, Campos M, et al. A new integrated variable based on thermometry, actimetry and body position (TAP) to evaluate circadian system status in humans. PLoS Comput Biol 2010;6:e1000996.